Skip to content

Comparison of the Effect of Total Intravenous Anesthesia and Inhalation Anesthesia on Cancer Cell Cytotoxicity, Micrometastasis and Recurrence of Tumor in Patients Undergoing Breast Tumor Resection

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02089178
Enrollment
48
Registered
2014-03-17
Start date
2014-02-28
Completion date
2014-12-30
Last updated
2019-03-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Cancer

Keywords

total intravenous anesthesia, inhalation anesthesia, cancer cell cytotoxicity, breast tumor

Brief summary

The purpose of this study is to compare the effect of total intravenous anesthesia and inhalation anesthesia on cancer cell cytotoxicity, micrometastasis and recurrence of tumor in patients undergoing breast tumor resection. Using propofol-remifentanil in total intravenous anesthesia group and sevoflurane -remifentanil in inhalation anesthesia group.

Interventions

total intravenous anesthesia group: propofol-remifentanil

PROCEDUREinhalation anesthesia

inhalation anesthesia group: sevoflurane-remifentanil

DRUGsevoflurane-remifentanil

Sponsors

Yonsei University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
FEMALE
Age
20 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* patient between 20 and 65 of age with ASA physical status Ⅰ-Ⅲ * breast cancer patients with no sign of local invasion (adjacent organs) and distant metastasis revealed by imaging studies * surgery performed by the same surgical team

Exclusion criteria

* ASA physical status Ⅳ * hepatic and renal impairment * diabetes or other endocrine disorders * body mass index \> 35 kg/m2 * immune disorders or immunosuppressive therapy * steroid treatment in the last 6 months * inflammation

Design outcomes

Primary

MeasureTime frameDescription
number of NK cellat 24 hour after surgery.comparison of the effect of total intravenous anesthesia and inhalation anesthesia on cancer cell cytotoxicity

Countries

South Korea

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026